Archives of Osteoporosis

, 9:166

Worldwide uptake of FRAX

Authors

    • WHO Collaborating Centre for Metabolic Bone DiseasesUniversity of Sheffield Medical School
  • H. Johansson
    • WHO Collaborating Centre for Metabolic Bone DiseasesUniversity of Sheffield Medical School
  • A. Oden
    • WHO Collaborating Centre for Metabolic Bone DiseasesUniversity of Sheffield Medical School
  • C. Cooper
    • MRC Lifecourse Epidemiology UnitUniversity of Southampton
    • NIHR Musculoskeletal Biomedical Research UnitUniversity of Oxford
  • E. V. McCloskey
    • WHO Collaborating Centre for Metabolic Bone DiseasesUniversity of Sheffield Medical School
  • Epidemiology and Quality of Life Working Group of IOF
Position Paper

DOI: 10.1007/s11657-013-0166-8

Cite this article as:
Kanis, J.A., Johansson, H., Oden, A. et al. Arch Osteoporos (2014) 9: 166. doi:10.1007/s11657-013-0166-8

Abstract

Summary

The worldwide uptake of FRAX is described.

Introduction

The aim of this report was to determine the usage of FRAX worldwide over a 1-year period from 1 May 2012.

Methods

The number of FRAX calculations from each country was assessed over a 1-year period and expressed as calculations per million of the population aged 50 years or more. Countries were colour coded according to usage to populate a world map.

Results

Over the index year, there were estimated to be 2,391,639 calculations sourced from 173 counties. Uptake was high in North America, the Antipodes and most countries of Europe; intermediate in Latin America and the Middle East; and very low in Africa and much of South East Asia.

Conclusions

It is expected that the comparative data will encourage the development of new FRAX models and the uptake of FRAX into assessment guidelines.

Keywords

FRAX Fracture risk assessment

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2014